Insights

Cutting-edge Technology MIMETAS offers innovative OrganoPlate UniFlow technology for drug development, providing a competitive edge to attract pharmaceutical companies seeking advanced solutions.

Collaboration Opportunities Strategic partnerships like the one with Astellas Pharma Inc present opportunities for joint ventures in immuno-oncological therapies, expanding market reach and revenue potential.

Recognition and Credibility Awards like the Dutch Innovation Prize 2022 position MIMETAS as an industry leader, enhancing the company's reputation and making it an attractive partner for collaborations and investments.

Diverse Product Offerings With a range of organoid-based products like ASC-derived Colon1 and Kidney2 Organoid tubules, MIMETAS caters to varying research needs, appealing to a broader customer base within the biotech sector.

Revenue and Expansion Potential Generating a revenue between $10M - 50M and securing funding of $3.5M indicate financial stability and growth potential, making MIMETAS an appealing prospect for businesses looking to invest in a financially sound partner.

MIMETAS Tech Stack

MIMETAS uses 8 technology products and services including Google Analytics Enhanced eCommerce, Microsoft Excel, Font Awesome, and more. Explore MIMETAS's tech stack below.

  • Google Analytics Enhanced eCommerce
    Analytics
  • Microsoft Excel
    Editors
  • Font Awesome
    Font Scripts
  • Google Font API
    Font Scripts
  • LinkedIn
    Online Community Software
  • Python
    Programming Languages
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics

Media & News

MIMETAS's Email Address Formats

MIMETAS uses at least 1 format(s):
MIMETAS Email FormatsExamplePercentage
F.Last@mimetas.comJ.Doe@mimetas.com
31%
First.Last@mimetas.comJohn.Doe@mimetas.com
21%
First@mimetas.comJohn@mimetas.com
17%
F.Last@mimetas.comJ.Doe@mimetas.com
31%

Frequently Asked Questions

Where is MIMETAS's headquarters located?

Minus sign iconPlus sign icon
MIMETAS's main headquarters is located at De Limes 7 Oegstgeest, 2342DH NL. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is MIMETAS's phone number?

Minus sign iconPlus sign icon
You can contact MIMETAS's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MIMETAS's official website and social media links?

Minus sign iconPlus sign icon
MIMETAS's official website is mimetas.com and has social profiles on LinkedIn.

How much revenue does MIMETAS generate?

Minus sign iconPlus sign icon
As of March 2025, MIMETAS's annual revenue reached $35M.

What is MIMETAS's SIC code NAICS code?

Minus sign iconPlus sign icon
MIMETAS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MIMETAS have currently?

Minus sign iconPlus sign icon
As of March 2025, MIMETAS has approximately 91 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer, Board Member, Founder: P. V.Chief Technology Officer: B. T.Vice President Sales And Marketing: M. D.. Explore MIMETAS's employee directory with LeadIQ.

What industry does MIMETAS belong to?

Minus sign iconPlus sign icon
MIMETAS operates in the Biotechnology Research industry.

What technology does MIMETAS use?

Minus sign iconPlus sign icon
MIMETAS's tech stack includes Google Analytics Enhanced eCommerceMicrosoft ExcelFont AwesomeGoogle Font APILinkedInPythonGoogle Tag ManagerGoogle Analytics.

What is MIMETAS's email format?

Minus sign iconPlus sign icon
MIMETAS's email format typically follows the pattern of . Find more MIMETAS email formats with LeadIQ.

How much funding has MIMETAS raised to date?

Minus sign iconPlus sign icon
As of March 2025, MIMETAS has raised $3.5M in funding. The last funding round occurred on Jan 01, 2019 for $3.5M.

When was MIMETAS founded?

Minus sign iconPlus sign icon
MIMETAS was founded in 2013.
MIMETAS

MIMETAS

Biotechnology ResearchOegstgeest, Netherlands51-200 Employees

We strive to contribute to groundbreaking therapies with our screenable, physiologically relevant 3D human disease models. By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases. 

For more information, visit: www.mimetas.com.

Section iconCompany Overview

Headquarters
De Limes 7 Oegstgeest, 2342DH NL
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $3.5M

    MIMETAS has raised a total of $3.5M of funding over 5 rounds. Their latest funding round was raised on Jan 01, 2019 in the amount of $3.5M.

  • $10M$50M

    MIMETAS's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $3.5M

    MIMETAS has raised a total of $3.5M of funding over 5 rounds. Their latest funding round was raised on Jan 01, 2019 in the amount of $3.5M.

  • $10M$50M

    MIMETAS's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.